Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Recent patent covers hydroxamic acid-based MMP inhibitors and their therapeutic use

Jan. 12, 2001

Inhibitors of p38 kinase and their use disclosed by Scios

Jan. 12, 2001

Centaur's rheumatoid arthritis drug advances to preclinical development

Jan. 12, 2001

New 3-pyridyl-4-arylpyrroles useful for inflammatory and AIDS-related disorders

Jan. 10, 2001

SR Pharma and Corixa broaden autoimmune diseases agreement

Jan. 10, 2001

Amarillo Biosciences reports completion of IFN-alpha phase III trial in Sjogren's syndrome

Jan. 8, 2001

Selective inhibitors of cathepsin S designed jointly by Medivir and Peptimmune

Jan. 8, 2001

Vertex commences phase II trial of VX-745 for rheumatoid arthritis

Jan. 8, 2001

Merck scientists disclose new series of imidazole-based cytokine inhibitors

Jan. 5, 2001

TNF-alpha-inhibitory thiazolopyrimidines patented by group at U. of California

Jan. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...